Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, <scp>MASLD</scp> , and Stage 3 chronic kidney disease: A 12‐month observational study Gaurab Bhaduri , Shambo Samrat Samajdar , Sanjay Bandyopadhyay +2 more 2025 Diabetes Obesity and Metabolism 0 citations